In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

To evaluate the clinical outcomes with optometrist pre-surgical insertion of DEXTENZA in the clinical office setting in patients undergoing same-day cataract surgery compared to standard of care steroid therapy.

Inclusion Criteria:

• Patients 18 years of age or older, undergoing routine, uncomplicated, sequential bilateral cataract surgery.
• Willing and able to comply with clinic visits and study related procedures
• Willing and able to sign the informed consent form

Exclusion Criteria:

• Patients under the age of 18.
• Patients who are pregnant (must be ruled out in women of childbearing age with pregnancy test).
• Active infectious ocular or systemic disease.
• Patients with active infectious ocular or extraocular disease.
• Patients actively treated with local or systemic immunosuppression including systemic corticosteroids.
• Patients with known hypersensitivity to Dexamethasone.
• Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator.
• Patients with proliferative diabetic retinopathy or uncontrolled diabetes as deemed by an A1C > 10.0.
• Patients with a history of ocular inflammation or macular edema.
• Patients with a pre-existing epiretinal membrane (ERM)
• Patients with allergy or inability to receive intracameral antibiotic.
• Patients on systemic non-steroidal anti-inflammatory drugs (NSAID) greater than 1,200 mg/day The PREPARE Study (V1) February, 2021 Page 27 CONFIDENTIAL
• Patients with a corticosteroid implant (i.e. Ozurdex).